Go Pro

Precigen (PGEN) Short Interest Ratio & Short Volume

Precigen logo
$7.44 +0.44 (+6.21%)
Closing price 03:59 PM Eastern
Extended Trading
$7.44 0.00 (0.00%)
As of 04:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Precigen Short Interest Overview

As of August 31, 2026, Precigen (PGEN) had a short interest of 42.18 million shares sold short, representing 20.19% of the public float. This marks a -0.14% decrease in short interest since the prior report. The short interest ratio (days to cover) is 7.9, meaning it would take 7.9 days of the average trading volume of 4.57 million shares to cover all short positions.

Current Short Interest
42,180,337 shares
Previous Short Interest
42,240,157 shares
Change Vs. Previous Month
-0.14%
Dollar Volume Sold Short
$292.31 million
Short Interest Ratio
7.9 Days to Cover
Last Record Date
August 31, 2026
Outstanding Shares
356,510,000 shares
Short Percent of Float
20.19%
Today's Trading Volume
3,708,080 shares
Average Trading Volume
4,569,489 shares
Today's Volume Vs. Average
81%
Short Selling Precigen?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Precigen and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

PGEN Short Interest Over Time

PGEN Days to Cover Over Time

PGEN Percentage of Float Shorted Over Time

Precigen Tesla Short Interest History & Recent Changes

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
8/31/202642,180,337 shares $292.31 million -0.1%20.2%7.91 $6.93
8/14/202642,240,157 shares $257.66 million +0.5%20.2%5.85 $6.10
7/31/202642,044,362 shares $263.62 million +2.5%20.1%11.12 $6.27
7/15/202641,025,860 shares $210.05 million -7.2%19.6%9.62 $5.12
6/30/202644,222,506 shares $252.07 million +2.0%21.2%7.61 $5.70
6/15/202643,338,122 shares $208.02 million +7.7%20.7%7.39 $4.80
5/29/202640,254,841 shares $174.71 million +1.0%21.3%9.56 $4.34
5/15/202639,871,277 shares $176.23 million +0.3%21.1%11.05 $4.42
4/30/202639,770,522 shares $165.45 million -0.1%21.1%14.51 $4.16
4/15/202639,794,906 shares $155.20 million +0.3%19.0%10.77 $3.90
3/31/202639,661,787 shares $153.49 million -0.3%19.0%5.62 $3.87
3/13/202639,788,994 shares $139.66 million -5.0%21.3%10.61 $3.51
2/27/202641,882,137 shares $158.73 million +1.9%22.4%7.54 $3.79
2/13/202641,094,402 shares $202.60 million -2.1%19.7%12.86 $4.93
1/30/202641,975,778 shares $188.47 million +6.5%22.4%11.67 $4.49
1/15/202639,413,898 shares $163.17 million +10.8%21.1%10.06 $4.14
12/31/202535,580,646 shares $148.73 million +28.2%19.0%5.15 $4.18
12/15/202527,758,985 shares $105.76 million -5.7%14.8%9.81 $3.81
11/28/202529,435,025 shares $112.88 million +1.9%15.7%6.77 $3.84
11/14/202528,884,978 shares $140.09 million -15.9%15.4%5.78 $4.85
10/31/202534,330,841 shares $142.13 million +7.1%21.8%7.46 $4.14
10/15/202532,040,000 shares $113.10 million -15.1%26.1%3.5 $3.53
9/30/202537,750,000 shares $124.20 million +6.8%30.8%4.3 $3.29
9/15/202535,350,000 shares $126.91 million -2.2%24.0%4.2 $3.59
8/31/202536,130,000 shares $162.95 million +16.9%24.5%4.8 $4.51
8/15/202530,910,000 shares $90.88 million +7.2%20.9%4.7 $2.94
7/31/202528,830,000 shares $49.30 million +1.4%19.7%12.3 $1.71
7/15/202528,430,000 shares $52.60 million -2.1%19.4%13.8 $1.85
6/30/202529,030,000 shares $41.22 million +6.4%19.9%16.1 $1.42
6/15/202527,280,000 shares $41.47 million -1.3%16.9%17.4 $1.52
5/31/202527,630,000 shares $36.47 million -3.9%17.1%18.1 $1.32
5/15/202528,740,000 shares $37.65 million +3.8%17.8%18 $1.31
4/30/202527,700,000 shares $43.21 million +9.2%17.0%16.7 $1.56
4/15/202525,360,000 shares $36.52 million +6.1%15.6%14.5 $1.44
3/31/202523,900,000 shares $35.61 million +5.5%14.7%13.1 $1.49
3/15/202522,660,000 shares $40.79 million +5.1%14.0%11.2 $1.80
2/28/202521,570,000 shares $37.32 million +13.2%13.3%10.8 $1.73
2/15/202519,050,000 shares $37.34 million +0.1%11.7%10 $1.96
1/31/202519,040,000 shares $25.70 million +1.0%11.7%11.4 $1.35
1/15/202518,860,000 shares $21.31 million +8.1%11.5%13.1 $1.13
Washington Is Broke—Could YOUR Savings Be Next? (Ad)

The Department of Justice recently argued in court that cash is not legally property, raising new questions for savers as federal debt continues to climb. Your IRA, 401k, and bank accounts are not hidden from view, prompting some Americans to look for ways to keep more control over their own wealth. A free information kit outlines three strategies people are considering to help shield their savings from future policy changes.tc pixel

Get the free information kit and explore savings strategies now
12/31/202417,450,000 shares $19.54 million -2.4%10.7%13.7 $1.12
12/15/202417,880,000 shares $12.07 million +5.6%12.1%20.7 $0.68
11/30/202416,940,000 shares $15.75 million +4.8%11.7%21.8 $0.93
11/15/202416,170,000 shares $13.26 million +5.6%11.2%20.6 $0.82
10/31/202415,320,000 shares $12.08 million -0.3%10.8%20.1 $0.79
10/15/202415,360,000 shares $13.35 million -2.2%10.8%16.4 $0.87
9/30/202415,700,000 shares $14.87 million +9.1%11.0%15.4 $0.95
9/15/202414,390,000 shares $15.11 million +10.4%10.1%14.1 $1.05
8/31/202413,030,000 shares $14.33 million -0.7%9.1%13.1 $1.10
8/15/202413,120,000 shares $14.04 million -5.2%10.7%12.3 $1.07
7/31/202413,840,000 shares $21.04 million +7.8%10.6%13.1 $1.52
7/15/202412,840,000 shares $21.12 million -2.4%9.8%15.1 $1.65
6/30/202413,160,000 shares $20.79 million +0.8%10.1%16.1 $1.58
6/15/202413,050,000 shares $21.27 million -2.0%10.0%15.9 $1.63
5/31/202413,320,000 shares $18.65 million -3.2%10.3%14.9 $1.40
5/15/202413,760,000 shares $19.81 million -9.5%10.7%15.4 $1.44
4/30/202415,210,000 shares $20.08 million -4.7%11.8%16 $1.32
4/15/202415,960,000 shares $22.34 million -5.6%13.0%15.8 $1.40
3/31/202416,900,000 shares $24.51 million -0.1%13.7%15.8 $1.45
3/15/202416,910,000 shares $24.18 million -2.1%13.7%14.3 $1.43
2/29/202417,270,000 shares $26.60 million -1.5%13.8%14.5 $1.54
2/15/202417,540,000 shares $25.08 million -6.3%14.0%15.1 $1.43
1/31/202418,710,000 shares $25.82 million -0.7%15.0%13.4 $1.38
1/15/202418,840,000 shares $25.81 million +4.7%15.1%13.2 $1.37
12/31/202317,990,000 shares $24.11 million +2.3%14.4%12.9 $1.34
12/15/202317,590,000 shares $21.46 million -3.1%14.1%13.2 $1.22
11/30/202318,150,000 shares $20.33 million +11.7%14.2%14.1 $1.12
11/15/202316,250,000 shares $17.23 million +2.3%12.7%11.6 $1.06
10/31/202315,880,000 shares $17.94 million +4.3%12.1%10.5 $1.13
10/15/202315,220,000 shares $18.26 million +1.7%11.6%10.1 $1.20
9/30/202314,970,000 shares $21.26 million -3.0%12.4%9.6 $1.42
9/15/202315,430,000 shares $22.99 million +12.7%12.8%9.8 $1.49
8/31/202313,690,000 shares $23.96 million +39.4%11.4%8.2 $1.75
8/15/20239,820,000 shares $15.02 million +13.1%8.2%6.1 $1.53
7/31/20238,680,000 shares $12.07 million -9.6%6.6%7 $1.39
7/15/20239,600,000 shares $11.33 million -3.0%7.3%7.9 $1.18
6/30/20239,900,000 shares $11.39 million +1.0%7.5%8.3 $1.15
6/15/20239,800,000 shares $12.45 million -8.9%7.4%7.1 $1.27
5/31/202310,760,000 shares $12.80 million -0.7%8.3%7.7 $1.19
5/15/202310,840,000 shares $13.12 million -3.9%8.3%7.2 $1.21
4/30/202311,280,000 shares $13.65 million -9.2%8.7%6.4 $1.21
4/15/202312,420,000 shares $13.04 million +0.3%9.6%5.3 $1.05
3/31/202312,380,000 shares $13.12 million +5.6%9.6%5.4 $1.06
3/15/202311,720,000 shares $12.89 million +5.7%9.1%5.6 $1.10
2/28/202311,090,000 shares $13.97 million +36.6%8.6%6 $1.26
2/15/20238,120,000 shares $12.26 million +1.3%6.3%4.7 $1.51
1/31/20238,020,000 shares $12.99 million +24.0%6.2%5.4 $1.62
1/15/20236,470,000 shares $13.00 million -4.7%6.6%6.4 $2.01
12/30/20226,790,000 shares $10.32 million +1.3%6.9%9.5 $1.52
12/15/20226,700,000 shares $10.99 million -5.0%6.8%9 $1.64
Gold majors have a big problem (Ad)

Newmont spent 15 billion dollars acquiring Newcrest in 2023, the largest deal in gold mining history. Yet production stayed at 5.9 million ounces, unchanged from 2020. Newmont, Barrick and Agnico all face the same reserve shortage, pushing majors toward acquiring smaller producing miners. Recent deals show the pattern: Rupert Resources jumped 67 percent and G2 Goldfields jumped 79 percent the day their buyouts were announced. Analyst Garrett Goggin has identified four junior miners he believes are next on the shopping list.tc pixel

See the four junior gold miners flagged as potential buyout targets
11/30/20227,050,000 shares $12.83 million -5.9%7.1%8.2 $1.82
11/15/20227,490,000 shares $14.61 million -5.0%7.6%8.2 $1.95
10/31/20227,880,000 shares $12.77 million -0.5%8.0%8.5 $1.62
10/15/20227,920,000 shares $13.62 million -1.3%8.1%7.8 $1.72
9/30/20228,020,000 shares $17.00 million -14.9%8.1%7 $2.12
9/15/20229,420,000 shares $25.72 million -9.4%9.5%6 $2.73
8/31/202210,400,000 shares $22.98 million -7.0%10.5%6.7 $2.21
8/15/202211,180,000 shares $29.29 million -5.4%11.2%7.1 $2.62
7/31/202211,820,000 shares $18.56 million -10.3%11.9%7.5 $1.57
7/15/202213,180,000 shares $22.27 million -26.6%13.3%8.7 $1.69
6/30/202217,950,000 shares $24.05 million -0.8%18.1%12 $1.34
6/15/202218,090,000 shares $23.52 million -1.7%18.2%15.7 $1.30
5/31/202218,400,000 shares $24.66 million -9.8%18.6%13 $1.34
5/15/202220,400,000 shares $27.54 million +3.5%20.7%13.7 $1.35
4/30/202219,710,000 shares $26.21 million +4.4%20.0%12.6 $1.33
4/15/202218,880,000 shares $33.61 million -1.1%19.1%10.7 $1.78
3/31/202219,090,000 shares $40.28 million -15.2%19.4%10.7 $2.11
3/15/202222,520,000 shares $43.69 million -1.1%22.8%12.3 $1.94
2/28/202222,780,000 shares $51.26 million -0.4%23.1%13.9 $2.25
2/15/202222,870,000 shares $50.54 million +26.2%23.1%13.6 $2.21
1/31/202218,120,000 shares $46.75 million +8.7%18.3%11 $2.58
1/15/202216,670,000 shares $53.84 million +9.0%16.8%11 $3.23
12/31/202115,300,000 shares $56.76 million +1.9%15.4%11.2 $3.71
12/15/202115,010,000 shares $56.59 million +1.8%15.1%11.5 $3.77
11/30/202114,750,000 shares $58.12 million +4.2%14.9%12 $3.94
11/15/202114,160,000 shares $56.07 million -4.9%14.1%11.7 $3.96
10/29/202114,890,000 shares $71.92 million -0.6%14.9%13.5 $4.83
10/15/202114,980,000 shares $69.66 million -2.6%15.0%15 $4.65
9/30/202115,380,000 shares $76.75 million -6.3%15.4%15.2 $4.99

PGEN Short Interest - Frequently Asked Questions

Short interest is the volume of Precigen shares that have been sold short but have not yet been closed out or covered. As of August 31st, investors have sold 42,180,337 shares of PGEN short. 20.19% of Precigen's shares are currently sold short. Learn More on Precigen's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PGEN shares currently have a short interest ratio of 7.9. Learn More on Precigen's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 20.19% of Precigen's floating shares are currently sold short.

Precigen saw a decline in short interest during the month of August. As of August 31st, there was short interest totaling 42,180,337 shares, a decline of 0.1% from the previous total of 42,240,157 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

20.19% of Precigen's shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Precigen: Abivax SA Sponsored ADR (7.98%), Praxis Precision Medicines, Inc. (13.81%), Kymera Therapeutics, Inc. (14.85%), Ionis Pharmaceuticals, Inc. (12.82%), Protagonist Therapeutics, Inc. (12.57%), Vaxcyte, Inc. (10.44%), Cytokinetics, Incorporated (14.39%), TG Therapeutics, Inc. (21.60%), ImmunityBio, Inc. (34.97%), Apogee Therapeutics Inc. (8.93%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($62.68 billion), Invesco QQQ ($47.06 billion), iShares Russell 2000 ETF ($23.54 billion), SPDR S&P Biotech ETF ($12.10 billion), Nebius Group N.V. ($9.34 billion), Western Digital Corporation ($8.96 billion), Financial Select Sector SPDR Fund ($8.16 billion), iShares 20+ Year Treasury Bond ETF ($7.98 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($7.52 billion), and VanEck Semiconductor ETF ($7.39 billion). View all of the most shorted stocks.

Short selling PGEN is an investing strategy that aims to generate trading profit from Precigen as its price is falling. PGEN shares are trading up $0.39 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Precigen occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PGEN, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PGEN, twice per month. The most recent reporting period available is August, 31 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like PGEN:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.



Short interest data for NASDAQ:PGEN is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 9/10/2026. FINRA publishes updated short interest twice a month.
From Our Partners